PARP9 and neoplasm: Remarkably, LOXL2 overexpression in PARP9 knockdown cells significantly attenuated apoptosis (Figure 4I) and enhanced resistance to DNA damage (Figure 4J), partially reversing the tumor-suppressive effects of PARP9 knockdown.